Anti-CD22 immunotoxin

From Wikipedia, the free encyclopedia

Anti-CD22 immunotoxin is a monoclonal antibody linked to a toxic substance. It is being studied in the treatment of some types of B-cell cancer. Anti-CD22 immunotoxin is made in the laboratory. It binds to CD22, a protein on the surface of normal B cells and B-cell tumors, and kills the cells.

[edit] External links

This article includes text from the U.S. National Cancer Institute's public domain Dictionary of Cancer Terms

 This oncology article is a stub. You can help Wikipedia by expanding it.
Tablets  This pharmacology-related article is a stub. You can help Wikipedia by expanding it.